体外毒性試験市場：技術、方法、用途、エンドユーザー産業別-世界予測2024-2030年

体外毒性試験市場規模は2023年に122億1,000万米ドルと推計され、2024年には134億9,000万米ドルに達し、CAGR 10.90％で2030年には252億1,000万米ドルに達すると予測されています。

体外毒性試験市場は、化学物質、医薬品、食品などの物質の毒性評価に細胞培養や臓器培養を採用しています。医薬品、化粧品、食品産業で使用されるこの革新的なアプローチは、精度、再現性、スピードにおいて大きなメリットをもたらします。試験方法の進歩、動物実験に対する考え方の高まり、費用対効果の高い安全対策へのニーズの高まりにより、市場は活況を呈しています。潜在的な成長領域は、医薬品や治療法の開発において、ヒトの生化学を忠実に模倣し、臨床試験の失敗の発生を最小限に抑えるin-vitroモデルを使用することにあります。さらに、ゲノミクスとプロテオミクスの進歩はかなりの成長機会をもたらします。しかし、この市場は、試験データの解釈の複雑さ、生体内条件の再現の難しさ、規制の複雑さといった課題に直面しており、これらすべてが高い運用コストの原因となっています。将来の事業成長は、コストを下げながら体外検査システムの予測精度を高めるための重点的な調査にかかっています。検査の認知・承認に関する規制当局との協力関係計算生物学やゲノム学の進歩、3D細胞培養や臓器チップシステムの革新は、消費者の安全基準を守りながら幅広い消費者層を確保し、市場拡大の原動力となります。

テクノロジー体外毒性試験テクノロジー選択の優先順位は、特定の研究ニーズによって大きく左右される

細胞培養技術は体外毒性試験の要です。これらの技術は、毒性のメカニズムを調査し、潜在的な毒性影響を予測するために、注意深く制御された条件下で細胞を培養することが多いです。これらの技術は通常、現実的な試験モデルや複雑な毒性解析に採用されます。ハイスループット技術は、サンプル処理とデータ解析を自動化することで、体外毒性試験を迅速化します。分子イメージングは、物質の毒性を理解する上で重要な、細胞および分子レベルでの生物学的プロセスを可視化しモニターする非侵襲的な方法を提供します。ゲノミクス、プロテオミクス、メタボロミクスなどを包含するOMICSテクノロジーは、有害物質の影響を受ける根本的な生物学的経路を探る。

方法毒性試験、薬物動態試験、薬力学試験における細胞アッセイの重要性

体外毒性試験は、物質の毒性を判定し、より安全な医薬化合物を開発する上で重要な役割を果たす複数の方法論を通じて発展してきました。体外毒性試験では、標的分子と低分子化合物との相互作用を詳細に調べる生化学的アッセイが製薬、バイオテクノロジー、研究機関で最も好まれている方法です。この手法は、潜在的な毒性物質を早期に特定することに主眼が置かれており、コストと時間効率が高いです。酵素アッセイ、受容体結合アッセイ、セカンドメッセンジャーアッセイなどの生化学的アッセイは、これらの相互作用の性質や潜在的な影響について必要な洞察を提供します。細胞アッセイは、化合物や治療に対する細胞の反応を一望できるため、体外毒性試験において重要な位置を占めています。ヒトの生理機能をより正確に模倣しているため、ニーズベースの嗜好性で高いスコアを獲得しています。これらのアッセイは、新規化合物の毒性、薬物動態、薬力学の決定に役立ちます。安全性評価、特に臓器特異的な毒性試験には、組織の器官型培養やスライス培養を用いる生体外法が好まれます。インシリコ法では、毒性評価のためにコンピュータ・シミュレーション・モデルを利用するが、非侵襲的で費用対効果が高く、迅速な試験が可能であることから、急速に普及しています。

応用：業界特有の要件に対応した正確で信頼性の高い結果を提供する一方で、試験方法の改善に注目が集まっています。

皮膚毒性は、3Dヒト皮膚モデルの作成と動物試験への依存度の低減により、産業界全体で皮膚関連製品や化学物質の使用が増加しているため、重要性を増しています。内分泌かく乱領域は、ホルモンバランスの乱れを引き起こし、健康や発育に影響を与える可能性のある物質を研究します。主要ヘルスケアベンダーは環境機関と協力して潜在的な内分泌かく乱物質のスクリーニングを強化し、化学的・生態学的毒性管理産業を奨励しています。眼毒性は、眼組織に害を及ぼす可能性のある物質を研究するもので、正確で再現性の高い眼毒性試験製品を提供することで、眼に特化した製品の安全性を高めています。全身毒性学は、物質が様々な身体系に与える影響を評価します。この試験ソリューションは、臓器毒性リスクを評価するための新しいサービスであり、医薬品製造におけるコストと開発時間を削減します。全体として、体外毒性試験は安全性評価の大きな可能性と大きな成長機会を提供しています。過去2年間は、業界特有の要件に対応した正確で信頼性の高い結果を提供しながら、試験方法の改善を目指した目覚ましい進歩が見られました。

最終用途：安全基準を確保するために食品・医薬品分野で活発に利用される試験管内試験

試験管内毒性試験は、多様なセクターの安全性を確保するものであり、各業界の異なるニーズに対応するために各業界特有の方法が採用されています。化学企業は、化学物質のプロファイリングに特化したin-vitro試験プラットフォームをリリースすることにより、有害な影響を確認し、人の健康と生態系を保護するためにin-vitro評価を継続的に進めています。消費者製品産業は、スキンケアや家庭用品におけるアレルギー性や刺激性を分析しながら、顧客の安全性を保証するために毒性試験を活用しています。食品メーカーは、病原体同定のための高度な体外試験キットを通じて、添加物の安全性評価に体外毒性試験を採用しています。創薬にとって重要な薬学における体外試験は、体外で提供されるものを利用することにより、毒性と有効性の理解を促進します。安全基準の向上と顧客の信頼は、進化する業界のニーズを反映したそれぞれの進歩により、体外毒性試験に大きく起因しています。

地域別の洞察

南北アメリカ、特に米国とカナダは、慢性疾患の蔓延による生物医学研究需要の高さから、in vitro毒性試験分野の先陣を切っています。政府のイニシアティブと市場リーダーの強固な存在が、その地位をさらに強化しています。欧州もまた、化学物質の登録・評価・認可・制限（REACH）法を含む法規制により、特に危険有害性の同定とリスク評価のための効率的で信頼性の高い試験方法への投資に拍車がかかり、試験管内試験に傾いています。中東・アフリカも、まだ始まったばかりではあるが、ヘルスケア分野への投資の増加や、世界の安全衛生規制への対応が急務となっていることから、高い潜在力を持つ市場です。中国、日本、インドなどのアジア太平洋諸国における消費者のダイナミックな需要が、この地域における体外検査の成長を後押ししています。例えば、中国では生物医学研究のための資金が増加しており、日本では堅固なヘルスケアのフレームワークと注目すべき研究促進政策の恩恵を受けています。EUのHorizon 2020プロジェクトや中国の国家自然科学基金（National Natural Science Foundation）など、世界のイニシアチブ、特許活動、研究の進歩は、体外毒性試験の不可欠な役割を強調しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは体外毒性試験市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、体外毒性試験市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.体外毒性試験市場の市場規模および予測は？

2.体外毒性試験市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.体外毒性試験市場の技術動向と規制枠組みは？

4.体外毒性試験市場における主要ベンダーの市場シェアは？

5.体外毒性試験市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 新規農薬・食品添加物の創薬・上市に向けた研究開発の取り組み
    • 医療機器評価における体外毒性試験の活用
  • 抑制要因
    • 技術的な限界と特定の生物学的現象を正確に再現できないこと
  • 機会
    • 体外毒性試験の進歩と毒性データの分析における計算生物学の採用
    • 残酷さのない試験方法を推進し、新しい毒性試験法を開発するための政府プログラム
  • 課題
    • 現在のモデルでは医薬品の承認が失敗する可能性。
• 市場セグメンテーション分析
  • テクノロジー：体外毒性試験テクノロジーの選択は、特定の調査ニーズによって大きく左右されます。
  • 方法：細胞アッセイは、毒性、薬物動態、薬力学のin vitro毒性試験において重要性を増しました。
  • アプリケーション：業界固有の要件に対応しながら、正確で信頼性の高い結果を提供しながらテスト方法を改善することへの関心が高まっています。
  • 最終用途：食品および医薬品分野で安全基準を確保するために積極的に使用されているin vitroテスト
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 体外毒性試験市場：技術別

• 細胞培養技術
• 高スループット技術
• 分子イメージング
• オミックス技術

第7章 体外毒性試験市場：方法別

• 生化学分析
• 細胞アッセイ
• 生体外
• シミュレーション

第8章 体外毒性試験市場：用途別

• 経皮毒性
• 内分泌かく乱
• 眼毒性
• 全身毒性学

第9章 体外毒性試験市場：エンドユーザー業界別

• 化学薬品
• 化粧品・家庭用品
• 食べ物
• 医薬品およびバイオ医薬品

第10章 南北アメリカの体外毒性試験市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の体外毒性試験市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの体外毒性試験市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • LGC Clinical Diagnostics、QC製品メーカーKova Internationalを買収
  • ERBCグループ、オンコファクトリーの買収により前臨床の専門知識を拡大
  • IIVSとToxys、インビトロ遺伝毒性評価用ToxTrackerの提供で契約を締結
• 戦略分析と提言

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH PROCESS
• FIGURE 2. IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. IN-VITRO TOXICOLOGY TESTING MARKET DYNAMICS
• FIGURE 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. IN-VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. IN-VITRO TOXICOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. IN-VITRO TOXICOLOGY TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY BIOCHEMICAL ASSAY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY BIOCHEMICAL ASSAY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELLULAR ASSAY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELLULAR ASSAY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY EX-VIVO, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY EX-VIVO, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY IN SILICO, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY IN SILICO, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DERMAL TOXICITY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DERMAL TOXICITY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ENDOCRINE DISRUPTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ENDOCRINE DISRUPTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OCCULAR TOXICITY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OCCULAR TOXICITY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SYSTEMIC TOXICOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SYSTEMIC TOXICOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CHEMICALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CHEMICALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC & HOUSEHOLD PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC & HOUSEHOLD PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY FOOD, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY FOOD, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS & BIOPHARMACEUTICALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS & BIOPHARMACEUTICALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 53. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 54. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 55. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 56. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 57. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 58. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 59. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 60. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 61. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 62. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 63. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 64. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 65. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 66. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 67. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 68. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 69. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 70. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 71. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 72. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 73. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 74. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 75. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 76. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 77. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 78. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 79. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 80. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 81. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 82. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 83. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 84. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 85. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 86. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 87. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 88. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 89. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 90. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 91. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 92. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 93. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 94. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 95. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 96. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 97. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 98. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 100. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 102. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 104. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 106. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 108. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 109. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 110. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 111. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 112. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 113. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 114. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 115. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 116. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 117. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 118. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 119. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 120. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 121. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 122. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 123. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 124. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 125. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 126. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 127. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 128. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 129. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 130. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 131. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 132. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 133. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 134. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 135. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 136. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 137. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 138. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 139. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 140. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 141. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 142. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 143. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 144. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 145. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 146. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 147. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 148. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 149. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 150. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 151. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 152. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 153. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 154. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 155. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 156. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 157. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 158. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 159. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 160. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 161. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 162. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 163. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 164. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 165. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 166. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 167. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 168. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 169. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 170. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 171. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 172. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 173. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 174. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 175. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 176. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 177. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 178. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 179. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 180. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 181. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 182. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 183. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 184. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 185. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 186. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 187. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 188. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 189. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 190. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 191. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 192. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 193. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 194. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 195. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 196. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 197. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 198. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 199. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 200. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 201. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 202. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 203. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 204. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 214. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 215. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 216. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 217. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 218. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 219. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 220. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 221. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 222. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 223. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 224. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 225. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 226. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 227. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 228. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 229. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 230. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 231. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 232. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 233. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 234. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 235. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 236. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 237. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 238. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 239. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 240. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 241. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 242. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 243. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 244. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 245. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 246. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 247. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 248. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 249. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 250. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 251. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 252. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 253. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 254. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 255. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 256. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 257. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 258. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 259. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 260. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 261. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 262. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 263. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 264. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 265. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 266. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 267. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 268. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 269. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 270. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 271. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 272. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 273. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 274. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 275. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 276. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 277. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 278. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 279. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 280. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 281. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 282. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 283. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 284. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 285. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 286. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 287. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 288. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 289. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 290. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 291. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 292. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 293. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 294. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 295. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 296. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 297. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 298. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 299. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 300. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 301. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 302. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 303. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 304. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 305. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 306. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 307. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 308. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 309. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 310. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 311. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 312. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 313. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 314. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 315. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 316. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 317. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
• TABLE 318. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
• TABLE 319. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 320. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 321. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 322. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY

[182 Pages Report] The In-Vitro Toxicology Testing Market size was estimated at USD 12.21 billion in 2023 and expected to reach USD 13.49 billion in 2024, at a CAGR 10.90% to reach USD 25.21 billion by 2030.

The in-vitro toxicology testing market employs cell cultures and organ cultures for toxicity evaluation of substances such as chemicals, drugs, and food. This innovative approach, used in pharmaceuticals, cosmetics, and the food industry, offers significant precision, repeatability, and speed benefits. The market is thriving due to advancements in testing methods, a rising ethos against animal testing, and the increased need for cost-effective safety measures. Potential growth areas lie in using in-vitro models in drug and therapeutic development, which closely mimic human biochemistry and minimize the occurrence of unsuccessful clinical trials. Further, the progress in genomics and proteomics presents considerable growth opportunities. The market, however, faces challenges such as the complexity of test data interpretation, the difficulty of replicating in-vivo conditions, and regulatory intricacies, all of which contribute to high operational costs. Future business growth hinges on focused research to enhance the predictive accuracy of in-vitro test systems while lowering costs. Collaborations with regulatory agencies for test recognition and approval advances in computational biology and genomics and innovations in 3D cell culture and organ-on-a-chip systems collectively drive market expansion, ensuring a broad consumer base is achieved while upholding consumer safety standards.

Technology: Preference for in-vitro toxicology testing technology selection largely depends by specific research needs

Cell culture technologies serve as the cornerstone of in-vitro toxicology testing. They often involve growing cells under carefully controlled conditions to investigate the mechanisms of toxicity and predict potential toxic effects. These technologies are typically employed for realistic test models and intricate toxicity analysis. High throughput technology expedites in-vitro toxicology testing by automating sample processing and data analysis. Molecular imaging offers a non-invasive method to visualize and monitor biological processes at the cellular and molecular level, critical for understanding substance toxicity. OMICS technology, which encapsulates genomics, proteomics, and metabolomics, among others, probes into the underlying biological pathways affected by toxic substances.

Method: Cellular assays gained importance in toxicity, pharmacokinetics and pharmacodynamics in vitro toxicology testing

In-vitro toxicology testing evolves through multiple methodologies, each playing a crucial role in determining the toxicity of substances and developing safer pharmaceutical compounds. In in-vitro toxicology testing, biochemical assays are the most favored methods by pharmaceutical, biotech, and research institutions since they involve detailed investigation of the interactions between a target and a small molecule. This technique predominantly focuses on identifying potential toxic substances early, making it cost and time-efficient. Biochemical assays such as enzymatic assays, receptor-binding assays, and second messenger assays provide necessary insights into the nature of these interactions and potential impacts. Cellular assays hold an imperative space in in-vitro toxicology testing by providing a panoramic view of the cell's response to a compound or a treatment. They score high on need-based preference as they mimic human physiology more accurately. These assays help determine new compounds' toxicity, pharmacokinetics, and pharmacodynamics. Ex-vivo methods, using organotypic or slice cultures of tissues, are favored for safety evaluations, especially for organ-specific toxicity testing. In Silico processes utilize computer-simulated models for toxicity evaluation, a burgeoning preference owing to their non-invasive, cost-effective, and speedy testing abilities.

Application: Rising focus on improving testing methods while delivering accurate, reliable results catering to industry-specific requirements

Dermal toxicity gained importance due to the growing use of skin-related products and chemicals across industries due to 3D human skin model creation and reducing the dependence on animal testing. The endocrine disruption domain studies substances that can cause hormonal imbalances, impacting health and development. Major healthcare vendors collaborate with environmental agencies to boost screening of potential endocrine disruptors, encouraging chemical and ecological toxicity control industries. Ocular toxicity involves studying substances that can harm eye tissue, as it provides accurate and reproducible ocular toxicity testing products, ensuring greater safety for eye-specific products. Systemic toxicology evaluates the impact of substances on various body systems. This testing solution is a novel service for assessing organ toxicity risks, reducing costs and development time in drug manufacturing. Overall, in-vitro toxicology testing offers significant safety evaluation potential with vast growth opportunities. The last two years saw remarkable advancements aimed at improving testing methods while delivering accurate, reliable results catering to industry-specific requirements.

End-Use: In vitro testing used vigorously in food and pharma sectors to ensure safety standards

In-vitro toxicology trials ensure safety across diverse sectors, with specific methods adopted for each industry to address their different needs. Chemical corporations continually advance in-vitro evaluations to ascertain hazardous effects and safeguard human health and the ecosystem by releasing a specialized in-vitro testing platform for chemical profiling. Consumer product industries take advantage of toxicology tests to guarantee customer safety while analyzing allergenicity and irritancy in skincare and household items. Food manufacturers employ in-vitro toxicology testing for the safety evaluation of their additives through advanced in-vitro testing kits for pathogen identification. Critical for drug discovery, in-vitro testing in pharmacy facilitates the understanding of toxicity and efficacy by utilizing its in-vitro offerings. Enhancement of safety standards and customer trust can be attributed significantly to in-vitro toxicology testing, with each advancement mirroring the evolving industry needs.

Regional Insights

The Americas, particularly the U.S., and Canada, spearheading the in vitro toxicology testing field due to high biomedical research demand from high chronic disease prevalence. Government initiatives and the robust presence of market leaders further bolster their position. Europe also leans towards in-vitro testing, with legislation including Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) law spurring investment into efficient and reliable testing methods, especially for hazard identification and risk assessment. Despite being nascent, the Middle East and Africa also demonstrate a high potential market, encouraged by the increased healthcare sector investment and the pressing need to comply with global health and safety regulations. Dynamic consumer demands in the Asia Pacific, including countries such as China, Japan, and India, propel the growth of in-vitro testing in this region. For example, China's funding for biomedical research is increasing, Japan benefits from a sturdy healthcare framework and notable pro-research policies, and healthcare investors are courting India's burgeoning economy. Global initiatives, patenting activities, and research advancements, such as the EU's Horizon 2020 project and China's National Natural Science Foundation funding, underscore the indispensable role of in-vitro toxicology testing.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In-Vitro Toxicology Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In-Vitro Toxicology Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Toxicology Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioIVT LLC, Charles River Laboratories International, Inc., Creative Bioarray, ERBC Group, Eurofins Scientific SE, Evotec SE, F. Hoffmann-La Roche AG, Gentronix Limited, HD Biosciences Co., Ltd., INDIGO Biosciences, Inc., Inotiv, Inc., InSphero AG, Intertek Group PLC, Laboratory Corporation of America Holdings, LAUS GmbH, LGC Limited, Merck KGaA, Microbac Laboratories Inc., Oroxcell SAS, Promega Corporation, Qiagen N.V., SGS SA, Thermo Fisher Scientific Inc., Toxys, Inc., Vimta Labs Ltd., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the In-Vitro Toxicology Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Technology
  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • OMICS Technology

• Method
  • Biochemical Assay
  • Cellular Assay
  • Ex-vivo
  • In Silico

• Application
  • Dermal Toxicity
  • Endocrine Disruption
  • Occular Toxicity
  • Systemic Toxicology

• End-User Industry
  • Chemicals
  • Cosmetic & Household Products
  • Food
  • Pharmaceuticals & Biopharmaceuticals

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the In-Vitro Toxicology Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the In-Vitro Toxicology Testing Market?

3. What are the technology trends and regulatory frameworks in the In-Vitro Toxicology Testing Market?

4. What is the market share of the leading vendors in the In-Vitro Toxicology Testing Market?

5. Which modes and strategic moves are suitable for entering the In-Vitro Toxicology Testing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. R&D initiatives for drug discovery and launch of novel agrochemicals and food additives
    • 5.1.1.2. Utilization of in-vitro toxicology testing for evaluation of medical devices
  • 5.1.2. Restraints
    • 5.1.2.1. Technical limitations and inability to accurately replicate certain biological phenomena
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in in-vitro toxicology testing and adoption of computational biology for analyzing toxicology data
    • 5.1.3.2. Government programs to promote cruelty-free testing methods and develop novel toxicology assays
  • 5.1.4. Challenges
    • 5.1.4.1. Chances of drug approval failures with the current models.
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Preference for in-vitro toxicology testing technology selection largely depends by specific research needs
  • 5.2.2. Method: Cellular assays gained importance in toxicity, pharmacokinetics and pharmacodynamics in vitro toxicology testing
  • 5.2.3. Application: Rising focus on improving testing methods while delivering accurate, reliable results catering to industry-specific requirements
  • 5.2.4. End-Use: In vitro testing used vigorously in food and pharma sectors to ensure safety standards
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. In-Vitro Toxicology Testing Market, by Technology

• 6.1. Introduction
• 6.2. Cell Culture Technology
• 6.3. High Throughput Technology
• 6.4. Molecular Imaging
• 6.5. OMICS Technology

7. In-Vitro Toxicology Testing Market, by Method

• 7.1. Introduction
• 7.2. Biochemical Assay
• 7.3. Cellular Assay
• 7.4. Ex-vivo
• 7.5. In Silico

8. In-Vitro Toxicology Testing Market, by Application

• 8.1. Introduction
• 8.2. Dermal Toxicity
• 8.3. Endocrine Disruption
• 8.4. Occular Toxicity
• 8.5. Systemic Toxicology

9. In-Vitro Toxicology Testing Market, by End-User Industry

• 9.1. Introduction
• 9.2. Chemicals
• 9.3. Cosmetic & Household Products
• 9.4. Food
• 9.5. Pharmaceuticals & Biopharmaceuticals

10. Americas In-Vitro Toxicology Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific In-Vitro Toxicology Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa In-Vitro Toxicology Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. LGC Clinical Diagnostics Acquires QC Product Maker Kova International
  • 13.3.2. ERBC Group Extends its Preclinical Expertise with the Acquisition of Oncofactory
  • 13.3.3. IIVS and Toxys Entered into an Agreement to Offer ToxTracker for In-Vitro Genetic Toxicity Evaluation
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio